Previous 10 | Next 10 |
OTC Markets Group Welcomes Cosmos Holdings Inc. to OTCQX PR Newswire NEW YORK, Nov. 25, 2020 NEW YORK , Nov. 25, 2020 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 11,000 U.S. and global securities, today announce...
Cosmos Holdings (COSM): Q3 GAAP EPS of $0.06.Revenue of $14.35M (+48.1% Y/Y)Press Release For further details see: Cosmos Holdings reports Q3 results
Revenue Increases 48%, Gross profit increased 210% to $2.39 million and Earnings Rise over Same 2019 Period Generics and Nutraceuticals Lead Expansion in Europe Robotic Automations Enhance Margins and Reduce Costs CHICAGO, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Cosmos Holdi...
Seasoned Entrepreneur Has Taken Several Companies f rom S tart- U p to IPO and has served on the boards of several NASDAQ and TSXV companies Appointment Follows Re c ent Board Selection of Peter Goldstein, Director and Principa...
CHICAGO, Oct. 16, 2020 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (the “Company") (OTCQB: COSM), an international pharmaceutical company, announced today that it has entered into an advisory agreement with PGS Ventures B.V. (PGS), an Amsterdam corporation (the Advisor), to identify an...
Cosmos Holdings ( OTCQB:COSM ) : Q2 GAAP EPS of $0.10. More news on: Cosmos Holdings Inc., Earnings news and commentary, Financial stocks news, , Read more ...
CHICAGO, Aug. 18, 2020 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (the “Company") (OTCQB: COSM), an international pharmaceutical company, announced consolidated financial results for the first six months ended June 30, 2020, prepared in accordance to Generally Accepted Accounting Prin...
Cosmos Holdings ( OTCQB:COSM ): Q1 Income from operations of $0.22M. More news on: Cosmos Holdings Inc., Earnings news and commentary, Financial stocks news, , Read more ...
CHICAGO, May 20, 2020 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (the ‘’Company") (OTCQB: COSM), an international pharmaceutical company, announced consolidated financial results for the fiscal year ended December 31, 2019 and the quarter ended March 31, 2020, prepared in accor...
CHICAGO, April 08, 2020 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. ("the Company") (OTCQB: COSM), an international pharmaceutical company, announced today that it has signed a definitive agreement with SunMed Biosciences Limited to be the exclusive representative and distribution agent of a ...
News, Short Squeeze, Breakout and More Instantly...
CHICAGO, IL / ACCESSWIRE / July 18, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and di...
CHICAGO, IL / ACCESSWIRE / July 10, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and di...
CHICAGO, IL / ACCESSWIRE / July 9, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and dis...